Skip to main content
The NEJM has featured an overview of Osteoarthritis of the Knee. https://t.co/1AaNICygOr

Dr. John Cush RheumNow ( View Tweet)

Jan 18, 2021
Adipose Transplants as a New Regulator of Osteoarthritis--A novel report from PNAS suggests that in osteoarthritis (OA), the damage is not entirely from body weight and mechanics, instead it may be from adipose tissue itself. Read more: https://t.co/0VpR4VPmBX
Dr. John Cush RheumNow ( View Tweet)
Jan 13, 2021

Adipose Transplants as a New Regulator of Osteoarthritis

Jan 11, 2021

A novel report from PNAS suggests that in osteoarthritis (OA), the damage is not entirely from body weight and mechanics, instead it may be from adipose tissue itself.

Read Article

EULAR Guidance on Patient Adherence to Meds

Jan 06, 2021

Non-adherence may be the single most untold risk to suboptimal outcomes in the care of musculoskeletal disease.  It has been estimated that 30-80% of patients with rheumatic and musculoskeletal diseases (RMDs) are nonadherent to prescribed regimens.  EULAR has commissioned a task force to

Read Article
Dr. Janet Pope ( @Janetbirdope) reviews Osteoarthritis studies presented at #ACR20. https://t.co/QMQ8DcsK0s https://t.co/W4w9BcsoCH
Dr. John Cush RheumNow ( View Tweet)
Dec 14, 2020

RheumNow Podcast – Stop These COVID Mistakes (12.11.20)

Dec 11, 2020

Dr. Jack Cush reviews the news and journal reports from this past week on RheumNow.com.

Read Article
#BestACR20Tweets RT @bella_mehta : Check out our work #racialdisparities in bilateral knee replacement -10 yr USA national study - ⬇️utilization in AA but NOT ⬆️complications.
Dr. John Cush RheumNow ( View Tweet)
Dec 08, 2020
Check out the latest from Dr. Bella Mehta ( @bella_mehta) #ACR20 Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis https://t.co/yataL7H8X4 https://t.co/xT1vCBDLyZ
Dr. John Cush RheumNow ( View Tweet)
Dec 05, 2020

Racial disparities in Bilateral Knee Arthroplasty in Osteoarthritis

Dec 01, 2020

Although arthritis-related activity, disabling work limitations, and severe pain (which are indications for TKA) disproportionately impact African American patients compared to White patients, there are marked racial disparities documented in utilization and complications in unilateral total

Read Article
What’s New in Knee Osteoarthritis that Matters? by Dr. Janet Pope ( @Janetbirdope) https://t.co/Ue3o8xAytV https://t.co/YaNftmH9ZN
Dr. John Cush RheumNow ( View Tweet)
Nov 24, 2020

What’s new in knee osteoarthritis that matters?

Are intra-articular steroid injections effective in symptomatic knee OA? Do they accelerate cartilage loss? Does weight less actually help? Do we have DMARDs for knee OA? Insights from 2020 ACR Convergence.

Read Article
Warfarin and End-Stage Osteoarthritis: Dr. David Liew ( @drdavidliew) #ACR20 https://t.co/hHZTL48DTI https://t.co/X4BDGBOGFq
Dr. John Cush RheumNow ( View Tweet)
Nov 22, 2020
#BestACR20Tweets RT @MeralElRamahiMD : When do you think we are going to get a DMARD for OA? 50% or more over age 60 will have osteoarthritis, yet we are yet to discover a promising disease modifying therapy. #ACR20 @ElaineHusniMD

Dr. John Cush RheumNow ( View Tweet)

Nov 21, 2020

Warfarin and End-Stage Osteoarthritis

Nov 18, 2020

Dr. David Liew discusses abstract #0934 - "Warfarin Use and Risk of Knee and Hip Replacements" - presented at the 2020 ACR annual meeting.

Read Article
#BestACR20Tweets RT @Janetbirdope : IA steroids for knee OA are superior to lidocaine! Clever RCT of 27 knee OA w either 40mg methylpred acetate + lidocaine vs lidocaine w social cues to exercise. Knee injury & OA outcome score superior for IA steroids in prelim data

Dr. John Cush RheumNow ( View Tweet)

Nov 17, 2020
Recognition and Early Treatment of MAS--Dr Olga Petryna ( @DrPetryna ) discusses two abstracts, abstract #1496 and #1149, presented at the #ACR20 annual meeting. https://t.co/Y3eymjYsgP https://t.co/qxHlmOyDLy
Dr. John Cush RheumNow ( View Tweet)
Nov 14, 2020
Listen to the Rheum Now podcast on Day 4 of the #ACR20 meeting. Topics: Belimumab in Lupus Nephritis, Enthesitis in PsA, Equity & Inclusion in Rheumatology Education, Osteoarthritis Studies, Outcomes of COVID in Rheumatic Disease Patients https://t.co/1PShHqX
Dr. John Cush RheumNow ( View Tweet)
Nov 11, 2020

Rheumatology Round-Up with Drs. Kavanaugh & Cush

Nov 10, 2020

The Annual Review of Best ACR 2020 abstracts featuring Drs. Cush and Kavanaugh filmed on the last day of Virtual ACR 2020 Nov. 9, 2020. Watch now!


Read Article
When do you think we are going to get a DMARD for OA? 50% or more over age 60 will have osteoarthritis, yet we are yet to discover a promising disease modifying therapy. #ACR20 @RheumNow @ElaineHusniMD

Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)

Nov 09, 2020
When you give IA steroids for knee OA how long do you tell pts it will work for @RheumNow #ACR20 @CRASCRRheum abstr#1650

Janet Pope Janetbirdope ( View Tweet)

Nov 09, 2020
Using a panel of urinary prtns, data from this study show transferrin, AGP1, ceruloplasmin, MCP1 & sVCAM1 are sig. ⬆in active LN pts. More studies req'd for confirmation. Utility in monitoring renal response to tx?
Nov 09, 2020
I recommend you don’t try this at home. Bariatric surgery may delay need for TKA in knee OA. Supports that et loss may help. Comparison study NOT RCT of 25 bariatric pts with knee OA compared to 28 with TKA abstr#1656 #ACR20 @RheumNow @CRASCRRheum

Janet Pope Janetbirdope ( View Tweet)

Nov 09, 2020
Intra-articulations steroids for the knee OA- finding benefits again! IA steroids were good then villified in press with accelerated cartilage loss.
Janet Pope Janetbirdope ( View Tweet)
Nov 09, 2020
Since MTX doesn’t work in cardiac prevention in non inflammatory pop’n (CIRT trial) should we use MTX in knee OA with inflammation? RCT n=344 w primary knee OA w swelling & pain.
Janet Pope Janetbirdope ( View Tweet)
Nov 09, 2020
#osteoarthritis Rx with #tanezumab - analgesic or DMOAD? RCT in knee OA of 3021 pts & only 1312 completed Rx.
Janet Pope Janetbirdope ( View Tweet)
Nov 09, 2020
×